Honzik, T, Tesarova, M, Magner, M, et al. Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis. J Inherit Metab Dis
2012; 35: 749–759.
Finsterer, J, Kothari, S. Cardiac manifestations of primary mitochondrial disorders. Int J Cardiol
2014; 177: 754–763.
Powell, CA, Kopajtich, R, D’Souza, AR, et al. TRMT5 mutations cause a defect in post-transcriptional modification of mitochondrial tRNA associated with multiple respiratory-chain deficiencies. Am J Hum Genet
2015; 97: 319–328.
Chung, WK, Martin, K, Jalas, C, et al. Mutations in COQ4, an essential component of coenzyme Q biosynthesis, cause lethal neonatal mitochondrial encephalomyopathy. J Med Genet
2015; 52: 627–635.
Stroud, DA, Maher, MJ, Lindau, C, et al. COA6 is a mitochondrial complex IV assembly factor critical for biogenesis of mtDNA-encoded COX2. Hum Mol Genet
2015; 24: 5404–5415.
Lax, NZ, Alston, CL, Schon, K, et al. Neuropathologic characterization of pontocerebellar hypoplasia type 6 associated with cardiomyopathy and hydrops fetalis and severe multisystem respiratory chain deficiency due to novel RARS2 mutations. J Neuropathol Exp Neurol
2015; 74: 688–703.
Alston, CL, Ceccatelli Berti, C, Blakely, EL, et al. A recessive homozygous p.Asp92Gly SDHD mutation causes prenatal cardiomyopathy and a severe mitochondrial complex II deficiency. Hum Genet
2015; 134: 869–879.
Haack, TB, Jackson, CB, Murayama, K, et al. Deficiency of ECHS1 causes mitochondrial encephalopathy with cardiac involvement. Ann Clin Transl Neurol
2015; 2: 492–509.
Shehata, BM, Cundiff, CA, Lee, K, et al. Exome sequencing of patients with histiocytoid cardiomyopathy reveals a de novo NDUFB11 mutation that plays a role in the pathogenesis of histiocytoid cardiomyopathy. Am J Med Genet A
2015; 167A: 2114–2121.
Brecht, M, Richardson, M, Taranath, A, Grist, S, Thorburn, D, Bratkovic, D. Leigh syndrome caused by the MT-ND5 m.13513G>a mutation: a case presenting with WPW-like conduction defect, cardiomyopathy, hypertension and hyponatraemia. JIMD Rep
2015; 19: 95–100.
Brisca, G, Fiorillo, C, Nesti, C, et al. Early onset cardiomyopathy associated with the mitochondrial tRNALeu((UUR)) 3271T>C MELAS mutation. Biochem Biophys Res Commun
2015; 458: 601–604.
Holmgren, D, Wahlander, H, Eriksson, BO, Oldfors, A, Holme, E, Tulinius, M. Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. Eur Heart J
2003; 24: 280–288.
Yaplito-Lee, J, Weintraub, R, Jamsen, K, Chow, CW, Thorburn, DR, Boneh, A. Cardiac manifestations in oxidative phosphorylation disorders of childhood. J Pediatr
2007; 150: 407–411.
Scaglia, F, Towbin, JA, Craigen, WJ, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics
2004; 114: 925–931.
Wahbi, K, Bougouin, W, Behin, A, et al. Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases. Eur Heart J
2015; 36: 2886–2893.
Honzik, T, Tesarova, M, Mayr, JA, et al. Mitochondrial encephalocardio-myopathy with early neonatal onset due to TMEM70 mutation. Arch Dis Child
2010; 95: 296–301.
Mazurova, S, Tesarova, M, Magner, M, et al. Novel mutations in the TAZ gene in patients with Barth syndrome. Prague Med Rep
2013; 114: 139–153.
Magner, M, Dvorakova, V, Tesarova, M, et al. TMEM70 deficiency: long-term outcome of 48 patients. J Inherit Metab Dis
2015; 38: 417–426.
Chanprasert, S, Wang, J, Weng, SW, et al. Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene. Mol Genet Metab
2013; 110: 153–161.
Gotz, A, Tyynismaa, H, Euro, L, et al. Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet
2011; 88: 635–642.
Taylor, RW, Pyle, A, Griffin, H, et al. Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. JAMA
2014; 312: 68–77.
Darley-Usmar, VM, Rickwood, D, Wilson, MT. Mitochondria, A Practical Approach. IRL Press, Oxford and Washington, DC, 1987, xvi, 321pp.
Rustin, P, Chretien, D, Bourgeron, T, et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta
1994; 228: 35–51.
Srere, PA, Brooks, GC. The circular dichroism of glucagon solutions. Arch Biochem Biophys
1969; 129: 708–710.
Schagger, H, von Jagow, G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem
1991; 199: 223–231.
Sheehan, DC, Hrapchak, BB. Theory and practice of histotechnology, 2nd ed. Battelle Press; Distributed by Lipshaw, Columbus, Ohio; Detroit, Michigan, 1987, xiii, 481 pp.
Pejznochova, M, Tesarova, M, Honzik, T, Hansikova, H, Magner, M, Zeman, J. The developmental changes in mitochondrial DNA content per cell in human cord blood leukocytes during gestation. Physiol Res
2008; 57: 947–955.
Schwarz, JM, Cooper, DN, Schuelke, M, Seelow, D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods
2014; 11: 361–362.
Adzhubei, IA, Schmidt, S, Peshkin, L, et al. A method and server for predicting damaging missense mutations. Nat Methods
2010; 7: 248–249.
Kumar, P, Henikoff, S, Ng, PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc
2009; 4: 1073–1081.
Copeland, WC. Defects in mitochondrial DNA replication and human disease. Crit Rev Biochem Mol Biol
2012; 47: 64–74.
Oskoui, M, Davidzon, G, Pascual, J, et al. Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol
2006; 63: 1122–1126.
Mancuso, M, Salviati, L, Sacconi, S, et al. Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA. Neurology
2002; 59: 1197–1202.
Galbiati, S, Bordoni, A, Papadimitriou, D, et al. New mutations in TK2 gene associated with mitochondrial DNA depletion. Pediatr Neurol
2006; 34: 177–185.
Tyynismaa, H, Sun, R, Ahola-Erkkila, S, et al. Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Hum Mol Genet
2012; 21: 66–75.
Marti, R, Nascimento, A, Colomer, J, et al. Hearing loss in a patient with the myopathic form of mitochondrial DNA depletion syndrome and a novel mutation in the TK2 gene. Pediatr Res
2010; 68: 151–154.
El-Hattab, AW, Scaglia, F., Mitochondrial, DNA. Depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics
2013; 10: 186–198.
Magner, M, Szentivanyi, K, Svandova, I, et al. Elevated CSF-lactate is a reliable marker of mitochondrial disorders in children even after brief seizures. Eur J Paediatr Neurol
2011; 15: 101–108.
Spinazzola, A, Invernizzi, F, Carrara, F, et al. Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis
2009; 32: 143–158.
Gotz, A, Isohanni, P, Pihko, H, et al. Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome. Brain
2008; 131 (Pt 11): 2841–2850.
Behin, A, Jardel, C, Claeys, KG, et al. Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum. Neurology
2012; 78: 644–648.
Paradas, C, Gutierrez Rios, P, Rivas, E, Carbonell, P, Hirano, M, DiMauro, S. TK2 mutation presenting as indolent myopathy. Neurology
2013; 80: 504–506.
Blakely, E, He, L, Gardner, JL, et al. Novel mutations in the TK2 gene associated with fatal mitochondrial DNA depletion myopathy. Neuromuscul Disord
2008; 18: 557–560.
Knierim, E, Seelow, D, Gill, E, von Moers, A, Schuelke, M. Clinical application of whole exome sequencing reveals a novel compound heterozygous TK2-mutation in two brothers with rapidly progressive combined muscle-brain atrophy, axonal neuropathy, and status epilepticus. Mitochondrion
2015; 20: 1–6.
Alston, CL, Schaefer, AM, Raman, P, et al. Late-onset respiratory failure due to TK2 mutations causing multiple mtDNA deletions. Neurology
2013; 81: 2051–2053.
et al. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet
2014; 133: 1–9.
Konovalova, S, Tyynismaa, H. Mitochondrial aminoacyl-tRNA synthetases in human disease. Mol Genet Metab
2013; 108: 206–211.
Sokabe, M, Ose, T, Nakamura, A, et al. The structure of alanyl-tRNA synthetase with editing domain. Proc Natl Acad Sci U S A
2009; 106: 11028–11033.
McLaughlin, HM, Sakaguchi, R, Giblin, W, et al. A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N). Hum Mutat
2012; 33: 244–253.
Zhao, Z, Hashiguchi, A, Hu, J, et al. Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy. Neurology
2012; 78: 1644–1649.
Dallabona, C, Diodato, D, Kevelam, SH, et al. Novel (ovario) leukodystrophy related to AARS2 mutations. Neurology
2014; 82: 2063–2071.
Sproule, DM, Kaufmann, P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci
2008; 1142: 133–158.
Euro, L, Konovalova, S, Asin-Cayuela, J, et al. Structural modeling of tissue-specific mitochondrial alanyl-tRNA synthetase (AARS2) defects predicts differential effects on aminoacylation. Front Genet
2015; 6: 21.